JPS5955820A - Plaster for adhesive salve preparation - Google Patents

Plaster for adhesive salve preparation

Info

Publication number
JPS5955820A
JPS5955820A JP16688882A JP16688882A JPS5955820A JP S5955820 A JPS5955820 A JP S5955820A JP 16688882 A JP16688882 A JP 16688882A JP 16688882 A JP16688882 A JP 16688882A JP S5955820 A JPS5955820 A JP S5955820A
Authority
JP
Japan
Prior art keywords
plaster
rubber
adhesive
sesamol
drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP16688882A
Other languages
Japanese (ja)
Inventor
Mareyoshi Sawaguchi
希能 澤口
Tetsuo Horiuchi
堀内 哲夫
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nitto Denko Corp
Original Assignee
Nitto Electric Industrial Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nitto Electric Industrial Co Ltd filed Critical Nitto Electric Industrial Co Ltd
Priority to JP16688882A priority Critical patent/JPS5955820A/en
Publication of JPS5955820A publication Critical patent/JPS5955820A/en
Pending legal-status Critical Current

Links

Abstract

PURPOSE:To provide a plaster for adhesive salve preparation having improved long-term preservation stability of the drug in the plaster, by compounding sesamol to a plaster composed of a rubber-based adhesive substance. CONSTITUTION:A plaster for adhesive salve preparation composed of a rubber- based adhesive mixture such as natural rubber, a synthetic rubber or their mixture, etc. is compounded with about 0.002-5wt%, especially about 0.01-2wt%, based on the whole plaster, of sesamol. The additive is effective to prevent the lowering of the drug action in the plster, especially action of a compound containing phenolic OH, e.g. a salicyclic acid derivative and an amino compound such as diphenhydramine, etc. which exhibits remarkable decrease of the content in said plaster. Sesame oil containing about 0.1wt% of sesamol or sesamoline produces sesamoline by hydrolysis can be used in place of sesamol, and a third component such as tackifier, etc. can be compounded to the above plaster.

Description

【発明の詳細な説明】 木兄Iジノ汀粘屑性貼付製剤用の判゛体及びこの・)一
体を使用した粘着性貼(−1製剤に関する。丈に詐しく
は木兄FJ’lは、粘着性貼付製剤用として険相される
ゴム系粘着性物質よりなる刺体の改良及び当該改良され
た骨休に5!に薬物を配合してなる粘矛i性貼イ」製剤
に関する。
[Detailed Description of the Invention] Kinei FJ'l relates to a form for adhesive patch preparations and an adhesive patch (-1 formulation) using the same. The present invention relates to an improvement in a patch made of a rubber-based adhesive substance which is considered to be suitable for use in adhesive patch preparations, and a viscous patch preparation comprising the improved bone paste and (5) a drug.

従来、外皮に投与する薬物は殺菌剤、消毒剤。Conventionally, the drugs administered to the outer skin are bactericides and disinfectants.

皮膚刺激剤などの外皮、その下部組織に局がr的に作用
させることを目的とするものであった。しかし、近年全
身作用を有する薬物をも外皮より投与する試みがなされ
ており、種々の薬物の外皮投与が提案ないし試みられて
いる。
The purpose was to have a topical effect on the outer skin and underlying tissue of skin irritants and the like. However, in recent years, attempts have been made to administer drugs that have systemic effects through the skin, and various drugs have been proposed or attempted to be administered through the skin.

薬物の外皮投与は、たとえば粘着性物質よりなる膏体に
薬物を配合した粘着性貼付製剤の形態にて行われるが、
当該1休として、ゴム系粘着性物質よりなる膏体を使用
した製剤を長1更保存した場合、薬物の分解、揮散なと
により、当該製剤による治療効果か著るしく低下する傾
向がある。
Dermal administration of drugs is carried out, for example, in the form of an adhesive patch, in which the drug is mixed into a plaster made of an adhesive substance.
When a preparation using a plaster made of a rubber-based adhesive substance is stored for a long period of time, the therapeutic effect of the preparation tends to be significantly reduced due to decomposition and volatilization of the drug.

ところで、薬物の揮散、光分解はアルミニウムラミネー
ト包装等によって密封、遮光することによってこれを防
止することができるが、ゴム系粘着性物質よりなる有体
に配合された薬物、とりわけフェノール性水酸基含有化
合物、アミン系化合物などは、アルミニウムラミネート
包装によっても薬物の分解がいぜんとして進行し、2〜
84f−の貯蔵によりて使用゛に耐えなくなるものも少
なくない。従って、薬物を配合しても当該薬物の分解が
進行しないゴム系粘着性物質よりなる膏体ないしゴム糸
粘石性貼+ll製剤の開発が望まれている。
By the way, volatilization and photodecomposition of drugs can be prevented by sealing them with aluminum laminate packaging and shielding them from light. , amine compounds, etc., the decomposition of drugs continues to proceed even with aluminum laminated packaging, resulting in
There are many items that become unusable due to storage of 84f-. Therefore, there is a need for the development of a plaster or a rubber-thread plaster preparation made of a rubber-based adhesive material in which the decomposition of the drug does not proceed even when the drug is mixed therein.

かかる実情下に本発明者らは神々研究を重ねてきたとこ
ろ、ゴム系粘着性物質よりなる膏体に1セザモール(s
esamol )を配合しておけば、当該膏体に薬物を
配合しても、薬物が分解することなく安定に存在−rる
ことを見出した。
Under these circumstances, the inventors of the present invention have repeatedly conducted research on the gods, and have found that 1 sezamol (s
It has been found that if esamol) is blended into the paste, the drug will not decompose and will exist stably even if the drug is blended into the paste.

木発引けかかる新知見に基づいて完成されたものであり
、ゴム系粘着性物質よりなる膏体に、セザモールを1合
してなる粘着性貼付製剤用1体及び当状刊体にさらに薬
物を配合してなる粘着性貼付製剤に関する。
It was completed based on the new findings from the tree development, and includes one adhesive patch preparation made of a paste made of a rubber-based adhesive substance and one part of sezamol, and a drug added to the present paper. This invention relates to an adhesive patch preparation.

木発[!1にて使用されるゴム系粘着性物質として成ゴ
ム、これらの混合物などがあげられる。合成ゴムとして
は、スチレン−インプレン−スチレン10ツク共重合体
ゴム、スチレシーブクジェンゴム、ポリフテンゴム、ポ
リインプレンゴム、グチルゴム、シリコーンゴムなどが
あけられる。ゴム糸枯f1性物員よりなる負体中には、
さらに第三j成分と[7で、デルベン系樹脂1朽油系樹
脂などの粘着伺与、剤、硫動パラフィン、動植物油(た
とえば、オリーブ油、大豆油、牛脂、トン脂)、ポリ1
デシ、低級イソプレン、ソックスなどの接着カー保持力
調整剤、酸化チタン、酸化亜鉛、メタ、ケイ酸アルミニ
ウム、硫酸カルシウム、リン酸カルシウムなどの充填剤
、水及び乳化剤(たとえば、ソルビタンモノオレエート
。ラウリルスルホン酸ナトリウム)、乳化助剤(た七え
ば、ステアリン酸マグネシウム、ステアリン酸アルミニ
ウム)などがあげられる。
Kihatsu [! Examples of the rubber adhesive substance used in 1 include synthetic rubber and mixtures thereof. Examples of the synthetic rubber include styrene-in-prene-styrene 10x copolymer rubber, styrene rubber, polyphthene rubber, polyin prene rubber, glutyl rubber, and silicone rubber. In the negative body consisting of rubber thread dead f1 member,
Furthermore, the third j component and [7, Derben-based resin 1] Adhesive agent such as oil-based resin, sulfur paraffin, animal and vegetable oil (for example, olive oil, soybean oil, beef tallow, tonne fat), poly 1
Adhesive car retention modifiers such as Deci, lower isoprene, socks, fillers such as titanium oxide, zinc oxide, meth, aluminum silicate, calcium sulfate, calcium phosphate, water and emulsifiers (e.g. sorbitan monooleate, lauryl sulfonic acid) (sodium), emulsifying aids (for example, magnesium stearate, aluminum stearate), etc.

本発明にて使用されるセザモールはゴマ油中に0.1重
量j程度含有されているので、ゴマ油又はゴマ油濃縮物
として膏体に配合してもよい。壕だ、セザモールはセザ
モリン(sesamo I in )の加水分解によっ
て得られるものであるから、木兄男膏体製進時にセザモ
リンの形態で配合しておいても膏体製造過程に加水分解
をうけてセザモールとなる。
Since sezamol used in the present invention is contained in sesame oil in an amount of about 0.1 weight j, it may be incorporated into the paste as sesame oil or sesame oil concentrate. Well, sezamol is obtained by hydrolysis of sesamolin (sesamo Iin), so even if it is mixed in the form of sezamolin at the time of making the plaster, it will not be hydrolyzed during the plaster manufacturing process. Becomes Cezamor.

従って、木兄+tihセザモールに代えてセザモリンを
配合する態様をも包含するものである。
Therefore, it also includes an embodiment in which sezamorin is blended in place of Kien + tih sezamol.

セザモールの添加量は、ゴム系粘着性物質よりなる膏体
に対して0.002〜5重量%程度、好葦しくは0.O
1〜2重量%程度であり、ゴマ油、ゴマ油濃縮物の形態
で添加する場合には、セザモールとして上記の配合割合
となるに相当′t−るH(を配合すればよい。
The amount of sezamol added is about 0.002 to 5% by weight, preferably 0.002 to 5% by weight, based on the paste made of a rubber-based adhesive substance. O
It is about 1 to 2% by weight, and when it is added in the form of sesame oil or sesame oil concentrate, it is sufficient to mix H(H) corresponding to the above blending ratio as sezamol.

木発すIの幹体は、外皮に適用しうる薬物を配合1−る
ことによって粘着1f1・貼+I製剤に製剤化−rるこ
とがでAる。面して、本発明に係る!1体を使111シ
た粘′:A件貼+Jf剤は、そこに配合された薬物が分
解さり、ることなく安定に保たれるという効果全有−す
る。
The trunk of the tree can be formulated into an adhesive 1f1/patch+I preparation by adding a drug that can be applied to the outer skin. Face to face, according to the present invention! The 111 viscous patch A + Jf agent has the full effect of keeping the drug compounded there stable without being decomposed.

本発明の・N体に配合される薬物は枯浩v1貼イ」製剤
に製剤化して投与されつる薬物であれば4.)に制限r
iなく、たとえば経皮吸収性薬物(ただし、経皮吸収助
剤などの助けによって経皮吸収されるものであってもよ
く、捷/ヒ局所性薬物、全1性薬物のいずれでもよい)
、皮膚疾患治療用薬物、皮膚刺激性薬物、不定愁訴治療
用薬物などがあげられる。特に、フェノール性水酸基含
伺化合物、アミン系化合物は従来のゴム系粘着性物質よ
りなる膏体中rおけるkW低下が著しいので、木発すn
t体はかかる業物を製剤化する場合に特にその慧義があ
る。フェノール性水酸基含有化合物としては、たとえば
サリチル酸誘導体(サリチル酸モノグリコール、サリチ
ル酸メチルなど)、ビタミンE及びその誘導体、カブサ
イシンなどがあけられ、またアミン系化合物としてはジ
フェンヒドラミンなどのエタノールアミン系抗ヒスタミ
ン薬物、クロルフエラミンなどのエチレンジアミン系抗
ヒスタミン薬物、リドカインなどがあげられる。その他
の薬効成分としては、たとえばt−メントール。
If the drug to be incorporated into the N-isomer of the present invention is a drug that is formulated and administered in a patch preparation, 4. ) limit r
For example, drugs that can be absorbed transdermally (however, they may be absorbed transdermally with the help of a transdermal absorption aid, and they may be topical drugs or all-one drug).
, drugs for treating skin diseases, drugs for skin irritation, drugs for treating indefinite complaints, etc. In particular, phenolic hydroxyl group-containing compounds and amine compounds have a significant reduction in kW in plasters made of conventional rubber-based adhesive substances, so
The t-form is particularly advantageous when formulating such products. Examples of compounds containing phenolic hydroxyl groups include salicylic acid derivatives (monoglycol salicylate, methyl salicylate, etc.), vitamin E and its derivatives, and kabsaicin, and examples of amine compounds include ethanolamine antihistamines such as diphenhydramine, and chloride. Examples include ethylenediamine antihistamine drugs such as feramine, and lidocaine. Other medicinal ingredients include, for example, t-menthol.

di−カンファー、チモール、d−ボルネオールなどの
急冷性皮膚刺激性薬物、インドメタシン。
Rapid skin irritation drugs such as di-camphor, thymol, d-borneol, and indomethacin.

シクロフェナックナトリウムなどの非ステロイトコネー
ト、アクリノール等の殺菌剤、トウガラシエキス、ノニ
ル酸パニリルアミド、カブザイシン。
Nonsteroid itoconates such as cyclofenac sodium, fungicides such as acrinol, hot pepper extract, nonylic acid panillylamide, cabzaicin.

ショウキョウエキス、カングリスチンキ、カンクリジン
などの温感性皮膚刺激性薬物、シコン、トウキ、サンシ
ミ。甘草、ショウキョウ、パンショウなどの生薬類など
かあけられる。
Warm-sensitive skin irritating drugs such as ginger extract, cangris tincture, and cancrisin, as well as ginger, ginger, and sun stains. You can also open herbal medicines such as licorice, ginger, and pansho.

なお、零発すJ粘着性貼付製剤の調製するKあたつては
、ゴム系粘析性物質に、まず薬物を添加した後にセザモ
ールを添加してもよいことにLいうまでもない1゜ fた、木兄明枯青性貼付製剤は、7rlj ??1’、
布、プラスチックフィルム等の支持体に展延して用いら
れる。
It goes without saying that when preparing the adhesive patch preparation that causes spillage, it is possible to first add the drug to the rubber-based sticky substance and then add cezamol. , Kinei Mei's anti-inflammatory patch preparation is 7rlj? ? 1',
It is used by spreading it on a support such as cloth or plastic film.

以下に実施例及び実験例を示して木兄り1をより具体的
に脱すノするが、本発明はこれらに限定されるもので雄
ない。
Examples and experimental examples will be shown below to more specifically overcome the limitations of Kimi et al. However, the present invention is not limited to these examples.

なお、以下の記載において「部」とあるは「重尾部」を
意味する。
In addition, in the following description, "part" means "jubibu".

実施例1 スチレンーグクジェンースチレンゴム43FISと天然
ロジン25都を、150”Cに保拐されたニーダ−で2
0分間練り、これにセザモール3部を加えて混合し、1
0分mj混練り°する。次にポリ1デシ2都、ゴマ前1
0部、酸化チタン粉末6部、タルク5都を添加し、10
分間混練りして粘着性貼付製剤用賞体を得る。
Example 1 Styrene-golden-styrene rubber 43FIS and 25 natural rosins were mixed in a kneader kept at 150"C.
Knead for 0 minutes, add 3 parts of Sezamol and mix, 1
Knead for 0 minutes. Next, poly 1 desi 2 cities, Gomae 1
0 parts, 6 parts of titanium oxide powder, 5 parts of talc added, 10 parts
Knead for minutes to obtain a body for adhesive patch preparation.

実施例2 実施例1にて得られた裏体に、90°Cにて、さらにサ
リチル酸モノグリコール5都、ノニル酸バニリルアミド
0.02部及びジフェンヒドラミン0.8部を加えて混
合し、織布上に0.2xrsの厚みで塗付して粘着性貼
付製剤を得る。
Example 2 5 monoglycol salicylate, 0.02 part of nonylic acid vanillylamide and 0.8 part of diphenhydramine were further added and mixed to the backing material obtained in Example 1 at 90°C, and the mixture was coated on a woven fabric. to obtain an adhesive patch preparation.

実施例3 実施例1におけるゴマ油の代りに値切パラフィンを用い
、実施例1及び実施例2と同様にして粘着性貼付製剤を
得る。
Example 3 An adhesive patch preparation was obtained in the same manner as in Example 1 and Example 2, using bargain paraffin instead of sesame oil in Example 1.

比較例1 実施例3の処方からセザモ〒〃を除き、実施例1及び2
と同様にして粘着性貼付製剤を得る。
Comparative Example 1 Excluding Sezamo from the formulation of Example 3, Example 1 and 2
An adhesive patch preparation is obtained in the same manner as above.

実施例 実施例2,3及び比較例1で得た製剤をアルミニウムー
ポリエチレンラミネートよりなる包装材にて遮光、密封
包装して40°Cにて3ケ月間保存した場合の薬物の分
解率(%)を調べ、その結果を第1表に示した。
Example Decomposition rate (%) of the drug when the preparations obtained in Examples 2 and 3 and Comparative Example 1 were stored at 40°C for 3 months in a light-shielded and sealed package made of aluminum-polyethylene laminate. ) and the results are shown in Table 1.

(以下余白) 第1表 薬物の分解率(係)(Margin below) Table 1 Drug degradation rate (section)

Claims (1)

【特許請求の範囲】[Claims] ゴム系粘貴性物v1よりなる刺体にセザモール全配合し
てなる粘着性貼付製剤用り体。
A body for an adhesive patch preparation comprising a stick body made of a rubber-based viscous material v1 and a whole compound of sezamol.
JP16688882A 1982-09-24 1982-09-24 Plaster for adhesive salve preparation Pending JPS5955820A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP16688882A JPS5955820A (en) 1982-09-24 1982-09-24 Plaster for adhesive salve preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP16688882A JPS5955820A (en) 1982-09-24 1982-09-24 Plaster for adhesive salve preparation

Publications (1)

Publication Number Publication Date
JPS5955820A true JPS5955820A (en) 1984-03-31

Family

ID=15839478

Family Applications (1)

Application Number Title Priority Date Filing Date
JP16688882A Pending JPS5955820A (en) 1982-09-24 1982-09-24 Plaster for adhesive salve preparation

Country Status (1)

Country Link
JP (1) JPS5955820A (en)

Similar Documents

Publication Publication Date Title
JPS59130811A (en) Plaster base for pharmaceutical preparation of adherent application
JPS5955820A (en) Plaster for adhesive salve preparation
JPS59181211A (en) Rubber based plaster composition
JPS5955823A (en) Plaster for adhesive salve preparation
RU2166933C1 (en) Sweat and feet hygienic deodorant, preparative form of hygienic deodorant and method of its preparation
JPS6053150A (en) Rubbery sticky bandage
JPH11180887A (en) Anti-inflammatory analgesic patch
JPS6056687B2 (en) Glue for adhesive patch preparations
JPS5955827A (en) Plaster for adhesive salve preparation
JPS5936609A (en) Adhesive application pharmaceutical
JPS5959612A (en) Plaster for adhesive salve preparation
JPS59184119A (en) Rubber-based adhesive plaster
JPS59128325A (en) Plaster for adhesive pharmaceutical
JPS59130810A (en) Plaster base for pharmaceutical preparation of adherent application
JPS5936611A (en) Adhesive application pharmaceutical
JPS59134714A (en) Tacky plaster base
JPS5953412A (en) Plaster for adhesive salve preparation
JPS6051108A (en) Rubber pressure-sensitive adhesive plaster
JPS59134718A (en) Tacky plaster base
JPS6053151A (en) Rubbery sticky bandage
JPS6051109A (en) Rubber pressure-sensitive adhesive plaster
JPS59130809A (en) Plaster base for pharmaceutical preparation of adherent application
JPS6051114A (en) Remedy and preventive for contact dermatitis
JPS59134717A (en) Tacky plaster base
JPS5955828A (en) Plaster for adhesive salve preparation